EMAMILTD

Emami Share Price

₹629.80 -13.35 (-2.08%)

21 Nov, 2024 14:44

SIP TrendupStart SIP in EMAMILTD

Start SIP

Performance

  • Low
  • ₹618
  • High
  • ₹643
  • 52 Week Low
  • ₹417
  • 52 Week High
  • ₹860
  • Open Price₹642
  • Previous Close₹643
  • Volume459,329

Investment Returns

  • Over 1 Month -10.59%
  • Over 3 Month -21.63%
  • Over 6 Month + 21.28%
  • Over 1 Year + 27.37%
SIP Lightning

Smart Investing Starts Here Start SIP with Emami for Steady Growth!

Invest Now

Emami Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 35.6
  • PEG Ratio
  • 3.3
  • Market Cap Cr
  • 27,491
  • P/B Ratio
  • 11.2
  • Average True Range
  • 29.82
  • EPS
  • 17.83
  • Dividend Yield
  • 1.3
  • MACD Signal
  • -18.51
  • RSI
  • 40.96
  • MFI
  • 41.07

Emami Financials

Emami Technicals

EMA & SMA

Current Price
₹629.80
-13.35 (-2.08%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹672.21
  • 50 Day
  • ₹704.85
  • 100 Day
  • ₹705.91
  • 200 Day
  • ₹659.92

Resistance and Support

635.03 Pivot Speed
  • R3 695.12
  • R2 672.38
  • R1 657.77
  • S1 620.42
  • S2 597.68
  • S3 583.07

What's your outlook on Emami?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Emami Ltd., is a leading Indian personal care and healthcare company. With renowned brands like BoroPlus and Navratna, it serves over 4.9 million retail outlets in India and exports to 70+ countries.

Emami has an operating revenue of Rs. 3,684.22 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of 22% is great, ROE of 29% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 79 which is a FAIR score but needs to improve its earnings, a RS Rating of 57 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 112 indicates it belongs to a poor industry group of Cosmetics/Personal Care and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Emami Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-07 Quarterly Results & Interim Dividend
2024-08-01 Quarterly Results
2024-05-29 Audited Results
2024-02-09 Quarterly Results & 2nd Interim Dividend
2023-11-06 Quarterly Results & Interim Dividend
Date Purpose Remarks
2024-11-18 INTERIM Rs.4.00 per share(400%)First Interim Dividend
2024-02-19 INTERIM Rs.4.00 per share(400%)Second Interim Dividend
2023-11-15 INTERIM Rs.4.00 per share(400%)Interim Dividend
2023-02-13 INTERIM Rs.4.00 per share (400%) Second Interim Dividend
2022-11-21 INTERIM Rs.4.00 per share(400%)Interim Dividend

Emami F&O

Emami Shareholding Pattern

54.84%
19.52%
1.55%
14.38%
0.01%
4.93%
4.77%

About Emami

  • NSE Symbol
  • EMAMILTD
  • BSE Symbol
  • 531162
  • ISIN
  • INE548C01032

Similar Stocks to Emami

Emami FAQs

Emami share price is ₹629 As on 21 November, 2024 | 14:30

The Market Cap of Emami is ₹27490.8 Cr As on 21 November, 2024 | 14:30

The P/E ratio of Emami is 35.6 As on 21 November, 2024 | 14:30

The PB ratio of Emami is 11.2 As on 21 November, 2024 | 14:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23